AbbVie is a leader in the pharmaceutical ... a double-digit dividend growth rate for several years. The credit and debit card issuer is attracting Millennials and Gen Z consumers.

The bottom line? AbbVie's post-Humira prospects look far better than investors are giving it credit for. The dividend is rock-solid and should continue growing along with the share price over the ...

AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth ...

Well before the market open, news broke of those two AbbVie price target increases. They came at the kickoff of the week, when the company was scheduled to post its fourth-quarter earnings (on ...

AbbVie (NYSE:ABBV) will report Q4 2024 results next week and provide guidance for 2025. The company is handling the erosion of Humira quite well, but the trajectory of the decline in Humira's net ...

Several major credit card companies have cards that offer roadside assistance without an annual membership fee.

AbbVie Inc (Symbol: ABBV) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $47.94B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including ...

Get a refund on sales tax, or special financing, when you use the B&H Payboo Credit Card at the iconic camera and video ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The card is only available for Mary Kay consultants and earns decent rewards. But a general-purpose card will offer more ...

There are some easy ways to offset these costs if you use the right credit card. CNBC Select analyzed over 30 popular rewards cards using an average American's annual budget and dug into each card ...